收藏切换
Research progress of injectable in situ hydrogel embolic agents
收藏切换
PDF
Xin-meng SHI1, 2, Ding QU1, 2, *, Yan CHEN1, 2, *
Acta Pharmaceutica Sinica | 2022, 57(3) : 644 - 657
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(3): 644-657
Reviews
Research progress of injectable in situ hydrogel embolic agents
Full
Xin-meng SHI1, 2, Ding QU1, 2, *, Yan CHEN1, 2, *
Affiliations
  • 1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
  • 2. Multi-component of Traditional Chinese Medicine and Microecology Research Center, Jiangsu Provincial Academy of Chinese Medicine, Nanjing 210028, China
Published: 2022-03-12 doi: 10.16438/j.0513-4870.2021-0883
Outline
收藏切换

Embolotherapy is a common method for clinical intervention in the treatment of diseases including aneurysms, arteriovenous malformations and solid tumors, and embolic agents are a decisive factor affecting the effect of embolization. Although various embolic agents like coils, microspheres, and Onyx have been used clinically, there are still some treatment limitations: such as weak blood vessel penetration, easy to aggregate, poor mechanical properties, adhesion to catheters, and the need for toxic solvents (e.g. dimethyl sulfoxide). In recent years, a number of studies have found that in situ hydrogels have good application prospects in the field of vascular embolization. When low viscosity precursor solution is injected into the targeted blood vessel via microcatheters, it will undergo a sol-gel transition through physical and/or chemical cross-linking to form hydrogel to block blood flow. In addition, these in situ hydrogels can load drugs by pore embedding, electrostatic interaction, chemical bonding, etc., and have excellent sustained-release properties. This review summarizes the research progress of injectable in situ hydrogel vascular embolic agents in the past ten years, with a view to provide references for the development of new embolic agents in the future.

embolic agent  /  hydrogel  /  injectable  /  in situ cross-linking  /  embolization
Xin-meng SHI, Ding QU, Yan CHEN. Research progress of injectable in situ hydrogel embolic agents[J]. Acta Pharmaceutica Sinica, 2022 , 57 (3) : 644 -657 . DOI: 10.16438/j.0513-4870.2021-0883
Year 2022 volume 57 Issue 3
PDF
213
80
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-0883
  • Receive Date:2021-06-17
  • Online Date:2025-12-22
  • Published:2022-03-12
Article Data
Affiliations
History
  • Received:2021-06-17
  • Revised:2021-07-26
Funding
Affiliations
    1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
    2. Multi-component of Traditional Chinese Medicine and Microecology Research Center, Jiangsu Provincial Academy of Chinese Medicine, Nanjing 210028, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-0883
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT